Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.

Tsang SH, Sampson JN, Schussler J, Porras C, Wagner S, Boland J, Cortes B, Lowy DR, Schiller JT, Schiffman M, Kemp TJ, Rodriguez AC, Quint W, Gail MH, Pinto LA, Gonzalez P, Hildesheim A, Kreimer AR, Herrero R; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2020 Feb 24. pii: djaa010. doi: 10.1093/jnci/djaa010. [Epub ahead of print]

PMID:
32091596
2.

Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial.

Kreimer AR, Sampson JN, Porras C, Schiller JT, Kemp T, Herrero R, Wagner S, Boland J, Schussler J, Lowy DR, Chanock S, Roberson D, Sierra MS, Tsang SH, Schiffman M, Rodriguez AC, Cortes B, Gail MH, Hildesheim A, Gonzalez P, Pinto LA; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2020 Feb 24. pii: djaa011. doi: 10.1093/jnci/djaa011. [Epub ahead of print]

PMID:
32091594
3.

Prioritisation of the human papillomavirus vaccine in a time of constrained supply.

Kreimer AR, Cernuschi T, Rees H, Saslow D, Porras C, Schiller J.

Lancet Child Adolesc Health. 2020 Feb 17. pii: S2352-4642(20)30038-9. doi: 10.1016/S2352-4642(20)30038-9. [Epub ahead of print] No abstract available.

PMID:
32078808
4.

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials.

Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D.

Vaccine. 2020 Feb 5;38(6):1302-1314. doi: 10.1016/j.vaccine.2019.12.017. Epub 2019 Dec 20. Review.

5.

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials.

Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, Wheeler CM, Hildesheim A; Costa Rica Vaccine Trial ; PATRICIA study .

J Natl Cancer Inst. 2019 Nov 7. pii: djz222. doi: 10.1093/jnci/djz222. [Epub ahead of print]

PMID:
31697384
6.

Identification and Massively Parallel Characterization of Regulatory Elements Driving Neural Induction.

Inoue F, Kreimer A, Ashuach T, Ahituv N, Yosef N.

Cell Stem Cell. 2019 Nov 7;25(5):713-727.e10. doi: 10.1016/j.stem.2019.09.010. Epub 2019 Oct 17.

7.

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.

Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, Quint W, Van Doorn LJ; CVT Group , Hildesheim A, Schiffman M, Wentzensen N.

J Infect Dis. 2019 Oct 8;220(10):1609-1619. doi: 10.1093/infdis/jiz324.

8.

MPRAnalyze: statistical framework for massively parallel reporter assays.

Ashuach T, Fischer DS, Kreimer A, Ahituv N, Theis FJ, Yosef N.

Genome Biol. 2019 Sep 2;20(1):183. doi: 10.1186/s13059-019-1787-z.

9.

Effectiveness of Levetiracetam as a First-Line Anticonvulsant for Neonatal Seizures.

Kreimer AM, Littrell RA, Gibson JB, Leung NR.

J Pediatr Pharmacol Ther. 2019 Jul-Aug;24(4):320-326. doi: 10.5863/1551-6776-24.4.320.

10.

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S Jr, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Heráclio SA, Clifford GM.

Lancet Infect Dis. 2019 Aug;19(8):880-891. doi: 10.1016/S1473-3099(19)30164-1. Epub 2019 Jun 13.

11.

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W, Weinstein SJ, Albanes D, Brenner N, Hoffman-Bolton J, Kaaks R, Barricarte A, Tjønneland A, Sacerdote C, Trichopoulou A, Vermeulen RCH, Huang WY, Freedman ND, Brennan P, Waterboer T, Johansson M.

Ann Oncol. 2019 Aug 1;30(8):1335-1343. doi: 10.1093/annonc/mdz138.

12.

Meta-analysis of massively parallel reporter assays enables prediction of regulatory function across cell types.

Kreimer A, Yan Z, Ahituv N, Yosef N.

Hum Mutat. 2019 Sep;40(9):1299-1313. doi: 10.1002/humu.23820. Epub 2019 Jun 18.

13.

Integration of multiple epigenomic marks improves prediction of variant impact in saturation mutagenesis reporter assay.

Shigaki D, Adato O, Adhikari AN, Dong S, Hawkins-Hooker A, Inoue F, Juven-Gershon T, Kenlay H, Martin B, Patra A, Penzar DD, Schubach M, Xiong C, Yan Z, Boyle AP, Kreimer A, Kulakovskiy IV, Reid J, Unger R, Yosef N, Shendure J, Ahituv N, Kircher M, Beer MA.

Hum Mutat. 2019 Sep;40(9):1280-1291. doi: 10.1002/humu.23797. Epub 2019 Jun 23.

PMID:
31106481
14.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

15.

An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.

Beachler DC, Pinto LA, Kemp TJ, Nyitray AG, Hildesheim A, Viscidi R, Schussler J, Kreimer AR, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):496-502. doi: 10.1158/1055-9965.EPI-17-0853. Epub 2018 Feb 23.

16.

Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.

Sampson JN, Hildesheim A, Herrero R, Gonzalez P, Kreimer AR, Gail MH.

Contemp Clin Trials. 2018 May;68:35-44. doi: 10.1016/j.cct.2018.02.010. Epub 2018 Feb 21.

17.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782. doi: 10.1016/j.vaccine.2017.12.078. Epub 2018 Feb 1.

18.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.

Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx158.

19.

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.

Lang Kuhs KA, Kreimer AR, Trivedi S, Holzinger D, Pawlita M, Pfeiffer RM, Gibson SP, Schmitt NC, Hildesheim A, Waterboer T, Ferris RL.

Cancer. 2017 Nov 15;123(22):4382-4390. doi: 10.1002/cncr.30966. Epub 2017 Sep 26.

20.

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, Steinberg M, Burdett L, Dean M, Roberson D, Mitchell J, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, Kreimer AR, Beachler DC, Hildesheim A, Gonzalez P, Porras C, Burk RD, Schiffman M.

Cell. 2017 Sep 7;170(6):1164-1174.e6. doi: 10.1016/j.cell.2017.08.001.

21.

Use antibiotics in cell culture with caution: genome-wide identification of antibiotic-induced changes in gene expression and regulation.

Ryu AH, Eckalbar WL, Kreimer A, Yosef N, Ahituv N.

Sci Rep. 2017 Aug 8;7(1):7533. doi: 10.1038/s41598-017-07757-w.

22.

The Natural History of Oral Human Papillomavirus in Young Costa Rican Women.

Beachler DC, Lang Kuhs KA, Struijk L, Schussler J, Herrero R, Porras C, Hildesheim A, Cortes B, Sampson J, Quint W, Gonzalez P, Kreimer AR.

Sex Transm Dis. 2017 Jul;44(7):442-449. doi: 10.1097/OLQ.0000000000000625.

23.

Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx005.

24.

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection.

Beachler DC, Waterboer T, Pierce Campbell ChM, Ingles DJ, Kuhs KA, Nyitray AG, Hildesheim A, Pawlita M, Kreimer AR, Giuliano AR.

Papillomavirus Res. 2016 Dec;2:141-144. doi: 10.1016/j.pvr.2016.07.003. Epub 2016 Jul 28.

25.

Predicting gene expression in massively parallel reporter assays: A comparative study.

Kreimer A, Zeng H, Edwards MD, Guo Y, Tian K, Shin S, Welch R, Wainberg M, Mohan R, Sinnott-Armstrong NA, Li Y, Eraslan G, Amin TB, Tewhey R, Sabeti PC, Goke J, Mueller NS, Kellis M, Kundaje A, Beer MA, Keles S, Gifford DK, Yosef N.

Hum Mutat. 2017 Sep;38(9):1240-1250. doi: 10.1002/humu.23197. Epub 2017 Mar 9.

26.

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.

Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WAJ, Porras C, Quint W, Rodriguez AC, Schiffman M, Schussler J, Skinner SR, Teixeira JC, Wheeler CM, Herrero R, Hildesheim A, Lehtinen M; Costa Rica Vaccine Trial and the PATRICIA study groups.

J Natl Cancer Inst. 2017 Jan 28;109(7). doi: 10.1093/jnci/djw300. Print 2017 Jan.

27.

HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States.

Beachler DC, Gonzales FA, Kobrin SC, Kreimer AR.

Papillomavirus Res. 2016 Dec;2:11-16. doi: 10.1016/j.pvr.2015.12.001. Epub 2015 Dec 28.

28.

Trends in cervical cancer incidence in younger US women from 2000 to 2013.

Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS.

Gynecol Oncol. 2017 Feb;144(2):391-395. doi: 10.1016/j.ygyno.2016.11.031. Epub 2016 Nov 26.

29.

Effect of HPV on cervical cancer screening in Alberta.

Brisson M, Drolet M, Bénard É, Kreimer AR.

CMAJ. 2016 Oct 4;188(14):1035. doi: 10.1503/cmaj.1150121. No abstract available.

30.

Combined effects of smoking and HPV16 in oropharyngeal cancer.

Anantharaman D, Muller DC, Lagiou P, Ahrens W, Holcátová I, Merletti F, Kjærheim K, Polesel J, Simonato L, Canova C, Castellsague X, Macfarlane TV, Znaor A, Thomson P, Robinson M, Conway DI, Healy CM, Tjønneland A, Westin U, Ekström J, Chang-Claude J, Kaaks R, Overvad K, Drogan D, Hallmans G, Laurell G, Bueno-de-Mesquita HB, Peeters PH, Agudo A, Larrañaga N, Travis RC, Palli D, Barricarte A, Trichopoulou A, George S, Trichopoulos D, Quirós JR, Grioni S, Sacerdote C, Navarro C, Sánchez MJ, Tumino R, Severi G, Boutron-Ruault MC, Clavel-Chapelon F, Panico S, Weiderpass E, Lund E, Gram IT, Riboli E, Pawlita M, Waterboer T, Kreimer AR, Johansson M, Brennan P.

Int J Epidemiol. 2016 Jun;45(3):752-61. doi: 10.1093/ije/dyw069. Epub 2016 May 19.

31.

Impact of pre-adapted HIV transmission.

Carlson JM, Du VY, Pfeifer N, Bansal A, Tan VY, Power K, Brumme CJ, Kreimer A, DeZiel CE, Fusi N, Schaefer M, Brockman MA, Gilmour J, Price MA, Kilembe W, Haubrich R, John M, Mallal S, Shapiro R, Frater J, Harrigan PR, Ndung'u T, Allen S, Heckerman D, Sidney J, Allen TM, Goulder PJ, Brumme ZL, Hunter E, Goepfert PA.

Nat Med. 2016 Jun;22(6):606-13. doi: 10.1038/nm.4100. Epub 2016 May 16.

32.

Characterization of human papillomavirus antibodies in individuals with head and neck cancer.

Lang Kuhs KA, Pawlita M, Gibson SP, Schmitt NC, Trivedi S, Argiris A, Kreimer AR, Ferris RL, Waterboer T.

Cancer Epidemiol. 2016 Jun;42:46-52. doi: 10.1016/j.canep.2016.03.003. Epub 2016 Mar 21.

33.

Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study.

Pierce Campbell CM, Viscidi RP, Torres BN, Lin HY, Fulp W, Abrahamsen M, Lazcano-Ponce E, Villa LL, Kreimer AR, Giuliano AR.

J Infect Dis. 2016 Jul 1;214(1):45-8. doi: 10.1093/infdis/jiw083. Epub 2016 Feb 29.

34.

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S.

Int J Cancer. 2016 Aug 1;139(3):510-7. doi: 10.1002/ijc.30063. Epub 2016 Mar 22. Review.

35.

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.

Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R; Costa Rica HPV Vaccine Trial (CVT) Group.

Am J Obstet Gynecol. 2016 Aug;215(2):212.e1-212.e15. doi: 10.1016/j.ajog.2016.02.021. Epub 2016 Feb 16.

36.

Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer.

Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, Kreimer AR, Hayes RB, Freedman ND, Burk RD.

JAMA Oncol. 2016 May 1;2(5):599-606. doi: 10.1001/jamaoncol.2015.5504.

37.

HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States.

Beachler DC, Gonzales FA, Kobrin SC, Kreimer AR.

Papillomavirus Res. 2016 Dec 1;2:11-16.

38.

Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.

Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N.

J Infect Dis. 2016 May 1;213(9):1444-54. doi: 10.1093/infdis/jiv753. Epub 2015 Dec 21. Review.

39.

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2015 Oct 14;108(1). pii: djv302. doi: 10.1093/jnci/djv302. Print 2016 Jan.

40.

Fewer than three doses of HPV vaccine - Authors' reply.

Kreimer AR, Struyf F, Hildesheim A, David MP, Wheeler CM; all authors of the manuscript.

Lancet Oncol. 2015 Sep;16(9):e424-e425. doi: 10.1016/S1470-2045(15)00196-5. No abstract available.

PMID:
26370346
41.

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial.

Panagiotou OA, Befano BL, Gonzalez P, Rodríguez AC, Herrero R, Schiller JT, Kreimer AR, Schiffman M, Hildesheim A, Wilcox AJ, Wacholder S; Costa Rica HPV Vaccine Trial (CVT) Group (see end of manuscript for full list of investigators).

BMJ. 2015 Sep 7;351:h4358. doi: 10.1136/bmj.h4358.

42.

Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior.

Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1548-56. doi: 10.1158/1055-9965.EPI-15-0044. Epub 2015 Jul 29.

43.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM; Costa Rica Vaccine Trial Study Group Authors, González P, Jiménez S, Lowy DR, Pinto LA, Porras C, Rodriguez AC, Safaeian M, Schiffman M, Schiller JT, Schussler J, Sherman ME; PATRICIA Study Group Authors, Bosch FX, Castellsague X, Chatterjee A, Chow SN, Descamps D, Diaz-Mitoma F, Dubin G, Germar MJ, Harper DM, Lewis DJ, Limson G, Naud P, Peters K, Poppe WA, Ramjattan B, Romanowski B, Salmeron J, Schwarz TF, Teixeira JC, Tjalma WA; HPV PATRICIA Principal Investigators/Co-Principal Investigator Collaborators; GSK Vaccines Clinical Study Support Group.

Lancet Oncol. 2015 Jul;16(7):775-86. doi: 10.1016/S1470-2045(15)00047-9. Epub 2015 Jun 9.

44.

Anthropometry and head and neck cancer:a pooled analysis of cohort data.

Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, Kreimer AR, Yang G, Adami HO, Alavanja MC, Beane Freeman LE, Boeing H, Buring J, Chaturvedi A, Chen Y, D'Aloisio AA, Freedman M, Gao YT, Gaziano JM, Giles GG, Håkansson N, Huang WY, Lee IM, Linet MS, MacInnis RJ, Park Y, Prizment A, Purdue MP, Riboli E, Robien K, Sandler DP, Schairer C, Sesso HD, Ou Shu X, White E, Wolk A, Xiang YB, Zelenuich-Jacquotte A, Zheng W, Patel AV, Hartge P, Berrington de González A, Gapstur SM.

Int J Epidemiol. 2015 Apr;44(2):673-81. doi: 10.1093/ije/dyv059. Epub 2015 Jun 6.

45.

NetCooperate: a network-based tool for inferring host-microbe and microbe-microbe cooperation.

Levy R, Carr R, Kreimer A, Freilich S, Borenstein E.

BMC Bioinformatics. 2015 May 17;16:164. doi: 10.1186/s12859-015-0588-y.

46.

The beginning of the end: vaccine prevention of HPV-driven cancers.

Giuliano AR, Kreimer AR, de Sanjose S.

J Natl Cancer Inst. 2015 Apr 24;107(6):djv128. doi: 10.1093/jnci/djv128. No abstract available.

PMID:
25911509
47.

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.

Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, Ocampo R, Schussler J, Lowy D, Guillen D, Stoler MH, Quint W, Morales J, Avila C, Rodriguez AC, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2015 Apr 27;33(18):2141-51. doi: 10.1016/j.vaccine.2015.03.015. Epub 2015 Mar 18.

48.

Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.

Kreimer AR, Brennan P, Lang Kuhs KA, Waterboer T, Clifford G, Franceschi S, Michel A, Willhauck-Fleckenstein M, Riboli E, Castellsagué X, Hildesheim A, Fortner RT, Kaaks R, Palli D, Ljuslinder I, Panico S, Clavel-Chapelon F, Boutron-Ruault MC, Mesrine S, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Cross AJ, Bueno-de-Mesquita HB, Vineis P, Larrañaga N, Pala V, Sánchez MJ, Navarro C, Barricarte A, Tumino R, Khaw KT, Wareham N, Boeing H, Steffen A, Travis RC, Quirós JR, Weiderpass E, Pawlita M, Johansson M.

J Clin Oncol. 2015 Mar 10;33(8):877-84. doi: 10.1200/JCO.2014.57.8435. Epub 2015 Feb 9.

49.

The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.

Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M.

J Natl Cancer Inst. 2015 Feb 2;107(3). pii: dju436. doi: 10.1093/jnci/dju436. Print 2015 Mar. No abstract available.

50.

Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.

Lang Kuhs KA, Anantharaman D, Waterboer T, Johansson M, Brennan P, Michel A, Willhauck-Fleckenstein M, Purdue MP, Holcátová I, Ahrens W, Lagiou P, Polesel J, Simonato L, Merletti F, Healy CM, Kjaerheim K, Conway DI, Macfarlane TV, Thomson P, Castellsagué X, Znaor A, Black A, Huang WY, Krogh V, Trichopoulou A, Bueno-de-Mesquita HB, Clavel-Chapelon F, Weiderpass E, Ekström J, Riboli E, Tjønneland A, Sánchez MJ, Travis RC, Hildesheim A, Pawlita M, Kreimer AR.

Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):683-9. doi: 10.1158/1055-9965.EPI-14-1217. Epub 2015 Jan 26.

Supplemental Content

Loading ...
Support Center